Michael Grey

Title: Michael Grey: Innovator in Pediatric Liver Disease Treatments

Introduction

Michael Grey is a notable inventor based in Rancho Santa Fe, CA (US). He has made significant contributions to the field of pediatric medicine, particularly in the treatment of liver diseases. With a total of 5 patents, his work focuses on innovative methods to improve the health outcomes of children suffering from cholestatic liver diseases.

Latest Patents

Among his latest patents, Michael Grey has developed bile acid recycling inhibitors aimed at treating pediatric cholestatic liver diseases. These methods involve non-systemically administering a therapeutically effective amount of an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTI) or a pharmaceutically acceptable salt thereof. His research also includes methods for decreasing serum bile acids, treating pruritis, and reducing liver enzymes. Additionally, he has worked on bile acid recycling inhibitors for hypercholemia and cholestatic liver disease, providing similar therapeutic approaches for these conditions.

Career Highlights

Michael Grey has held positions in reputable companies such as Shire Human Genetic Therapies, Inc. and Lumena Pharmaceuticals LLC. His work in these organizations has allowed him to advance his research and contribute to the development of effective treatments for liver diseases.

Collaborations

Throughout his career, Michael has collaborated with notable professionals, including Bronislava Gedulin and Niall O'Donnell. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Michael Grey's contributions to pediatric liver disease treatments through his innovative patents and collaborations highlight his commitment to improving children's health. His work continues to pave the way for advancements in medical therapies.